Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Anika Therapeutics (NASDAQ:ANIK) reported its Q4 earnings results on Wednesday, March 13, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Anika Therapeutics beat estimated earnings by 119.0%, reporting an EPS of $0.05 versus an estimate of $-0.26.
Revenue was up $3.35 million from the same period last year.
Last quarter the company beat on EPS by $0.37 which was followed by a 11.0% increase in the share price the next day.
Here's a look at Anika Therapeutics's past performance:
Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
---|---|---|---|---|
EPS Estimate | -0.37 | -0.27 | -0.30 | -0.24 |
EPS Actual | 0 | 0.06 | -0.36 | -0.21 |
Revenue Estimate | 38.27M | 40.56M | 37.28M | 37.70M |
Revenue Actual | 41.47M | 44.30M | 37.92M | 39.62M |
To track all earnings releases for Anika Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: ANIK